Response: We remain committed to the Excessive Radiation eCQM as a patient safety issue and affirm, as we did in the CY 2024 OPPS/ASC final rule (88 FR 81987), that the measure's data elements are scientifically and practically valid
80: 485-500.e7
Mid-range treatments per the brand include NAD+ nasal spray starting at $125, injectable GLP-1 treatments starting at $139, compounded liraglutide starting at $149, NAD+ patches starting at $160, and sermorelin nasal spray starting at $199
Apparently, Sermorelin, GHRP-2, and another GHRP increased IGF-1 from about 160 ng/mL at baseline to roughly 250265 ng/mL
Does this product page provide dosing or human-use guidance
If unpublished studies with null or negative findings had existed and been included, the overall effect estimate might have been attenuated